Why Is enGene Therapeutics Stock Falling Friday?

enGene Therapeutics Inc. (NASDAQ:ENGN) shares are trading sharply lower Friday. The decline follows the company’s Thursday announcement of updated interim results from its Phase 2 LEGEND trial. A wave of analyst downgrades on Friday morning has fueled the sell-off....